TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21913862

Group type: EXPERIMENTAL
Intervention: Home bleaching (Opalescence 35% Carbamide Peroxide)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Chemically activated office bleaching (Opalescence Xtra Boost 38% Hydrogen Peroxide)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Light-activated office bleaching (Opalescence Xtra 35% Hydrogen Peroxide)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Home and chemically activated bleaching systems
Number of subjects: 30
Study: 18984493

Group type: EXPERIMENTAL
Intervention: Group-based program for obese children and adolescents consisting of modules for physical activity, nutritional education, and coping strategies performed twice each week for 1 year with parental participation and medical supervision.
Number of subjects: 73

Group type: COMPARATOR
Intervention: Written therapeutic advice during a visit at 0 and 6 months in the outpatient clinic.
Number of subjects: 73
Study: 16706813

Group type: EXPERIMENTAL
Intervention: Nutrient drink
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nutrient drink and Water
Number of subjects: 30
Study: 12582838

Group type: EXPERIMENTAL
Intervention: GABA(A) agonist lorazepam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repetitive training (motor learning task)
Number of subjects: 0
Study: 11078104

Group type: EXPERIMENTAL
Intervention: Random practice schedule
Number of subjects: 0

Group type: COMPARATOR
Intervention: Blocked practice schedule
Number of subjects: 0
Study: 9206051

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen therapy (20mg daily for 2 to 5 years)
Number of subjects: 874

Group type: COMPARATOR
Intervention: No tamoxifen therapy (control group)
Number of subjects: 874
Study: 8154420

Group type: EXPERIMENTAL
Intervention: Left ventricular aneurysm patients
Number of subjects: 2494

Group type: COMPARATOR
Intervention: No wall motion abnormalities
Number of subjects: 2494
Study: 2835055

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH) 2,500 U s.c. once daily
Number of subjects: 231

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH) 5,000 U s.c. twice daily with dihydroergotamine (DHE) 0.5 mg s.c.
Number of subjects: 231
Study: 31424354

Group type: EXPERIMENTAL
Intervention: 15-min Stroop task
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 30-min Stroop task
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 30064032

Group type: EXPERIMENTAL
Intervention: Palm oil
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Palm oil plus Sn solution
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sn solution (positive control)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Deionized water (negative control)
Number of subjects: 16
Study: 28283026

Group type: EXPERIMENTAL
Intervention: Levonorgestrel Intrauterine System (LNG-IUS)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate injection (DMPA)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Combined oral contraceptive pill (COCP)
Number of subjects: 77

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 77
Study: 25528326

Group type: EXPERIMENTAL
Intervention: Diet-related colorectal cancer prevention beliefs
Number of subjects: 169
Study: 23735957

Group type: EXPERIMENTAL
Intervention: Intraventricular application of recombinant tissue‐type plasminogen activator and lateral rotational therapy (experimental)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 60
Study: 20464617

Group type: COMPARATOR
Intervention: GONB and TPIs using lidocaine 2% and bupivacaine 0.5% + saline (group A)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: GONB and TPIs using lidocaine 2% and bupivacaine 0.5% + triamcinolone 40 mg (group B)
Number of subjects: 37
Study: 18467729

Group type: EXPERIMENTAL
Intervention: Cisplatin/fluorouracil/vincristine (CFV)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Cisplatin/doxorubicin (CD)
Number of subjects: 173
Study: 16371294

Group type: EXPERIMENTAL
Intervention: Nestorone/ethinylestradiol vaginal ring inserted during the follicular phase for 7 consecutive days
Number of subjects: 48
Study: 14609894

Group type: EXPERIMENTAL
Intervention: Topical application of 1 g of EMLA 60 to 90 minutes before lumbar puncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10907384

Group type: EXPERIMENTAL
Intervention: Canalith repositioning procedure (CRP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham maneuver
Number of subjects: 50
Study: 8677067

Group type: EXPERIMENTAL
Intervention: Dexamethasone (5 mg every 12 hours for a total of four doses)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Dexamethasone (in singleton analysis)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo (in singleton analysis)
Number of subjects: 124
Study: 1464896

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg single dose)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Captopril (2 x 25 mg for two weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6206035

Group type: EXPERIMENTAL
Intervention: cis‐platinum plus bleomycin
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: methotrexate plus vindesine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: surgery
Number of subjects: 28
Study: 30677137

Group type: EXPERIMENTAL
Intervention: Generalized estimating equations (GEE)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Conventional statistical tests (t-tests and ANOVAs)
Number of subjects: 2000
Study: 27892822

Group type: EXPERIMENTAL
Intervention: EG2 (‐) - text focusing on negative changes
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: EG1 (+/‐) - text focusing on negative and positive premenstrual changes
Number of subjects: 241

Group type: COMPARATOR
Intervention: CG - control group text
Number of subjects: 241
Study: 27061082

Group type: EXPERIMENTAL
Intervention: Amrubicin and cisplatin (AP)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Etoposide and cisplatin (EP)
Number of subjects: 300
Study: 24270933

Group type: EXPERIMENTAL
Intervention: IV morphine 0.1 mg/kg with promethazine 25 mg
Number of subjects: 59

Group type: COMPARATOR
Intervention: IV morphine 0.1 mg/kg
Number of subjects: 59
Study: 22506833

Group type: EXPERIMENTAL
Intervention: Intraosseous injection with the X‐Tip system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Periodontal ligament injections (PDL)
Number of subjects: 40
Study: 20558628

Group type: EXPERIMENTAL
Intervention: Elevated baseline transpulmonary gradient (TPG)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Elevated pulmonary vascular resistance index (PVRi)
Number of subjects: 501
Study: 17355300

Group type: EXPERIMENTAL
Intervention: Calcium supplementation during pregnancy
Number of subjects: 414
Study: 16285944

Group type: EXPERIMENTAL
Intervention: Synthetic human PYY3-36 (0.2, 0.4, and 0.8 pmol.kg(‐1).min(‐1))
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic human PYY3-36
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic human PYY3-36 (highest dose)
Number of subjects: 0
Study: 12087119

Group type: EXPERIMENTAL
Intervention: CD‐ROM‐based multimedia program titled 'Forgetfulness: What's Normal and What's Not'
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: CD‐ROM‐based multimedia program
Number of subjects: 113
Study: 10461281

Group type: EXPERIMENTAL
Intervention: Health Promoting Schools intervention
Number of subjects: 22
Study: 8545306

Group type: EXPERIMENTAL
Intervention: Nursing interventions to encourage parents to use well-child services
Number of subjects: 2053

Group type: COMPARATOR
Intervention: Control group (families without phones)
Number of subjects: 2053
Study: 2143063

Group type: EXPERIMENTAL
Intervention: Intra-arterial floxuridine
Number of subjects: 74

Group type: COMPARATOR
Intervention: Intravenous fluorouracil
Number of subjects: 74
Study: 422100

Group type: EXPERIMENTAL
Intervention: Benzbromarone (50 mg to 100 mg/day)
Number of subjects: 16
Study: 31935779

Group type: EXPERIMENTAL
Intervention: Multi-activity HIIT (20 minutes during PE classes, 2 times a week for 3 months)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Multi-activity HIIT
Number of subjects: 46
Study: 30076087

Group type: EXPERIMENTAL
Intervention: Probiotic
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Synbiotic
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 27932595

Group type: EXPERIMENTAL
Intervention: Not regularly cleaning the container used for transporting water for household consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Living in villages with larger concentrations of cattle and having more livestock sharing the same water source as for human consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cleaning the water container
Number of subjects: 0
Study: 25782422

Group type: EXPERIMENTAL
Intervention: D2 (ergocalciferol)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: D3 (cholecalciferol)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 23456752

Group type: EXPERIMENTAL
Intervention: Solid meal (bars) with water
Number of subjects: 40

Group type: COMPARATOR
Intervention: Liquid meal (shakes)
Number of subjects: 40
Study: 21874538

Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg once daily for 12 weeks
Number of subjects: 355

Group type: COMPARATOR
Intervention: Simvastatin 40 mg once daily for 12 weeks
Number of subjects: 355

Group type: EXPERIMENTAL
Intervention: Pitavastatin 4 mg
Number of subjects: 355

Group type: COMPARATOR
Intervention: Simvastatin 40 mg
Number of subjects: 355
Study: 19673654

Group type: EXPERIMENTAL
Intervention: Retroperitoneal laparoscopic radical nephrectomy
Number of subjects: 352

Group type: COMPARATOR
Intervention: Open radical nephrectomy
Number of subjects: 352
Study: 16686577

Group type: EXPERIMENTAL
Intervention: Plyometric training (JUMP group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Physical education program (CONT group)
Number of subjects: 30
Study: 15292747

Group type: EXPERIMENTAL
Intervention: 2-year physical education program (curricular materials, staff development, on-site follow-up)
Number of subjects: 25000

Group type: COMPARATOR
Intervention: Control schools (usual programs)
Number of subjects: 25000
Study: 11770034

Group type: EXPERIMENTAL
Intervention: Ultrafiltration (UF)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study: 9006584

Group type: EXPERIMENTAL
Intervention: Growth hormone replacement therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy
Number of subjects: 0
Study: 8501479

Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire
Number of subjects: 150

Group type: COMPARATOR
Intervention: Interviewer-administered questionnaire
Number of subjects: 150
Study: 2888253

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Morphine-Scopolamine (Mo-Scop)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study: 28887245

Group type: EXPERIMENTAL
Intervention: Pulsatile Fresh Frozen Human Cadaver Circulation Model (PHCM)
Number of subjects: 12
Study: 27667332

Group type: EXPERIMENTAL
Intervention: Intradermal delivery of virosomal vaccine using MicronJet600™
Number of subjects: 370

Group type: COMPARATOR
Intervention: 45μg dose of virosomal vaccine formulation
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 370
Study: 25266414

Group type: EXPERIMENTAL
Intervention: Fresh gas flow rate of 2 l/min (group D2)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Fresh gas flow rate of 4 l/min (group D4)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Fresh gas flow rate of 6 l/min (group D6)
Number of subjects: 105
Study: 22644708

Group type: EXPERIMENTAL
Intervention: Insulin-loaded HA nanoparticles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Insulin solution
Number of subjects: 0
Study: 20356587

Group type: EXPERIMENTAL
Intervention: Metformin (M)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Naltrexone (N)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combination of oral contraceptives (OC) and prednisolone (OC/Pr)
Number of subjects: 29
Study: 18177922

Group type: EXPERIMENTAL
Intervention: Coxibs
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional NSAIDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NSAIDs (including coxibs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose lumiracoxib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lumiracoxib
Number of subjects: 0
Study: 16484767

Group type: EXPERIMENTAL
Intervention: Ethanolic placebo (12 microl 96% ethanol + 0.13 mug EDTA/actuation)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Aqueous placebo (12 microl water + 5.5 microg EDTA + 1.1 mug BAC/actuation)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Normal saline (12 microl 0.9% sodium chloride/actuation)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Ethanolic placebo vs Normal saline
Number of subjects: 37

Group type: COMPARATOR
Intervention: Aqueous placebo vs Normal saline
Number of subjects: 37
Study: 14584556

Group type: EXPERIMENTAL
Intervention: Left dorsolateral lesions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Medial lesions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Right dorsolateral lesions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 18
Study: 10925684

Group type: EXPERIMENTAL
Intervention: Regimen A (CMF: cyclophosphamide 100 mg/body on days 1‐14; methotrexate 40 mg/m2 on days 1 and 8; 5‐fluorouracil 500 mg/m2 on days 1 and 8)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Regimen B (UFT 300 mg/day and tamoxifen 30 mg/day for 2 years)
Number of subjects: 44
Study: 8844884

Group type: EXPERIMENTAL
Intervention: Radiotherapy doses ranging from 0.4 to 5.2 Gy per fraction
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Radiotherapy doses less than 1.5 Gy per fraction
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Various treatment fractions (5, 10, 12, and 20 daily treatment fractions)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Prostatic irradiation (30-32 fractions)
Number of subjects: 117
Study: 1397244

Group type: EXPERIMENTAL
Intervention: Fresh platelet concentrates (PC)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Stored platelet concentrates (PC)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: PC stored 0‐1 d
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: PC stored 2‐3 d
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: PC stored 4‐5 d
Number of subjects: 39
Study: 4029019

Group type: EXPERIMENTAL
Intervention: 0.5g temocillin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 1g temocillin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Both doses (0.5g and 1g)
Number of subjects: 6
Study: 29801486

Group type: EXPERIMENTAL
Intervention: Probiotic Bio-Kult® (14 different bacterial strains)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Probiotic Bio-Kult®
Number of subjects: 400
Study: 27484227

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-ketamine (DK)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Dexmedetomidine-midazolam-fentanyl (DMF)
Number of subjects: 56
Study: 24444221

Group type: EXPERIMENTAL
Intervention: Relaxing music for anxiety control
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Non-relaxing music
Number of subjects: 72

Group type: COMPARATOR
Intervention: No music control
Number of subjects: 72
Study: 22228772

Group type: EXPERIMENTAL
Intervention: Screening with stress myocardial perfusion imaging (MPI)
Number of subjects: 1123

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 1123
Study: 20350033

Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 134
Study: 18509970

Group type: EXPERIMENTAL
Intervention: Preoperative plateletpheresis combined with intraoperative autotransfusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intraoperative autotransfusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: No managements of blood conservation
Number of subjects: 60
Study: 16210963

Group type: EXPERIMENTAL
Intervention: Alemtuzumab with low-dose cyclosporine (CsA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard therapy (full doses of CsA with azathioprine and corticosteroids)
Number of subjects: 30
Study: 12078913

Group type: EXPERIMENTAL
Intervention: Escalated BEACOPP (eight cycles)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Escalated BEACOPP (four escalated cycles followed by four at baseline dose)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 221

Group type: COMPARATOR
Intervention: ABVD (eight cycles)
Number of subjects: 221
Study: 10422019

Group type: EXPERIMENTAL
Intervention: Isoniazid plus Rifampicin (HR) for 6 or 9 months with radical surgical resection and bone grafting, plus Streptomycin for 6 months (Hong Kong)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoniazid plus Rifampicin (HR) for 6 or 9 months (Madras)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isoniazid plus Ethambutol (EH) for 9 or 18 months or Isoniazid plus PAS (PH) (Korea)
Number of subjects: 0
Study: 7545380

Group type: EXPERIMENTAL
Intervention: DDAVP infusion (group I)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Saline infusion (group II)
Number of subjects: 23
Study: 2209496

Group type: EXPERIMENTAL
Intervention: Epinephrine (Group A)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Epinephrine plus thrombin (Group B)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Epinephrine (Group A) and Epinephrine plus thrombin (Group B)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Re-injected patients after second endoscopy
Number of subjects: 64
Study: 7237899

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 17

Group type: COMPARATOR
Intervention: Methyldopa
Number of subjects: 17
Study: 31941834

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PCI)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 422
Study: 30353743

Group type: EXPERIMENTAL
Intervention: Lixisenatide (20 μg, 8 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Insulin glulisine (titrated once-daily)
Number of subjects: 35
Study: 29151458

Group type: EXPERIMENTAL
Intervention: Home bleaching (HB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: In-office bleaching (OB)
Number of subjects: 40
Study: 25641260

Group type: EXPERIMENTAL
Intervention: Gla‐300
Number of subjects: 878
Study: 23795871

Group type: EXPERIMENTAL
Intervention: Substance use treatment (Brief Strategic Family Therapy)
Number of subjects: 480
Study: 20645126

Group type: EXPERIMENTAL
Intervention: Control over the initial contingent negative variation (iCNV)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Control over the terminal contingent negative variation (tCNV)
Number of subjects: 24
Study: 18819961

Group type: EXPERIMENTAL
Intervention: High-dose aspirin (>/=200 mg)
Number of subjects: 2658

Group type: EXPERIMENTAL
Intervention: Moderate-dose aspirin (101-199 mg)
Number of subjects: 2658

Group type: COMPARATOR
Intervention: Low-dose aspirin (</=100 mg)
Number of subjects: 2658

Group type: COMPARATOR
Intervention: High-dose aspirin (>/=200 mg) vs Low-dose aspirin (</=100 mg)
Number of subjects: 2658
Study: 17377079

Group type: EXPERIMENTAL
Intervention: Levosimendan 0.1 microg [corrected] x kg(‐1) x min(‐1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Milrinone 0.5 microg [corrected] x kg(‐1) x min(‐1)
Number of subjects: 30
Study: 14994265

Group type: EXPERIMENTAL
Intervention: Feeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention to visual stimuli
Number of subjects: 0
Study: 11371485

Group type: COMPARATOR
Intervention: Granisetron 40 microg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ramosetron 6 microg/kg
Number of subjects: 80
Study: 9702614

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5% albumin
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All three diluents
Number of subjects: 60
Study: 7977774

Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 0.5 ml.kg‐1.min‐1 (group I)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 1.0 ml.kg‐1.min‐1 (group II)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 2.0 ml.kg‐1.min‐1 (group III)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 4.0 ml.kg‐1.min‐1 (group IV)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 10% amino acid solution infused at 6.0 ml.kg‐1.min‐1 (group V)
Number of subjects: 8
Study: 2466449

Group type: EXPERIMENTAL
Intervention: 10% pentastarch
Number of subjects: 0

Group type: COMPARATOR
Intervention: 5% albumin
Number of subjects: 0
Study: 31868684

Group type: EXPERIMENTAL
Intervention: Levodopa (regular dose)
Number of subjects: 37
Study: 30536129

Group type: EXPERIMENTAL
Intervention: nCRT
Number of subjects: 220

Group type: COMPARATOR
Intervention: nCT
Number of subjects: 220
Study: 26750388

Group type: EXPERIMENTAL
Intervention: 12-week Cognitive Behavioural Therapy-based group treatment for hoarding disorder
Number of subjects: 77
Study: 25807028

Group type: EXPERIMENTAL
Intervention: Increased bar velocity group (IVG)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Reduced bar velocity group (RVG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 24
Study: 23553154

Group type: EXPERIMENTAL
Intervention: Powdered black tea solids (3 cups/d)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Flavonoid‐free caffeine‐matched beverage (control)
Number of subjects: 111